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Open-cell versus closed-cell stent design differences
in blood flow velocities after carotid stenting
Damon S. Pierce, MD, Eric B. Rosero, MD, J. Gregory Modrall, MD, Beverley Adams-Huet, MS,
R. James Valentine, MD, G. Patrick Clagett, MD, and Carlos H. Timaran, MD Dallas, Tex
Objective: The differential effect of open-cell vs closed-cell stent design configuration on carotid velocities detected by
duplex ultrasound (DUS) imaging has not been established. To identify possible stent design differences in carotid
velocities, we analyzed DUS studies obtained before and immediately after carotid artery stenting (CAS).
Methods: In a series of 141 CAS procedures performed during a 3-year period, data from the first postinterventional DUS
images and carotid angiograms were evaluated for each patient. Peak systolic velocities (PSV), end-diastolic velocities
(EDV), and internal carotid artery/common carotid artery (ICA/CCA) PSV ratios were compared according to stent
design. Differences in carotid velocities were analyzed using nonparametric statistical tests.
Results:Completion angiograms revealed successful revascularization and<30% residual stenosis in each case. The 30-day
stroke-death rate in this series was 1.6% and was unrelated to stent type. Postintervention DUS images were obtained a
median of 5 days (interquartile range [IQR], 1-25 days) after CAS. Closed-cell stents were used in 41 procedures (29%)
and open-cell stents in 100 (71%). The median PSV was 95.9 cm/s (IQR, 77-123 cm/s) for open-cell stents and 122
cm/s (IQR, 89-143 cm/s) for closed-cell stents, which was significantly higher (P  .007). Closed-cell stents also had
significantly higher median EDVs (36 vs 29 cm/s; P .006) and ICA/CCA PSV ratios (1.6 vs 1.1; P .017). By DUS
criteria, the carotid velocities in 45% of closed-cell stents exceeded the threshold of 50% stenosis for a nonstented artery
compared with 26% of open-cell stents (P .04). Closed-cell stents had a 2.2-fold increased risk of yielding abnormally
elevated carotid velocities after CAS compared with open-cell stents (odds ratio, 2.2; 95% confidence interval, 1.02-4.9).
Conclusions: Carotid velocities are disproportionately elevated after CAS with closed-cell stents compared with open-cell
stents. This suggests that the velocity criteria for quantifying stenosis may require modification according to stent design.
The importance of these differences in carotid velocities related to stent design and the potential relationship with
recurrent stenosis remains to be established. (J Vasc Surg 2009;49:602-6.)Carotid artery stenting (CAS) with cerebral protection
is an effective alternative for the treatment of carotid steno-
sis in selected patients, particularly those with significant
comorbidities or a hostile neck from previous surgical pro-
cedures or radiation.1-3 Carotid stents of different design
and configuration are available. Depending on the density
of struts, stents can be classified as those with a closed-cell
or an open-cell configuration.4 Closed-cell stents are char-
acterized by small free cell areas between struts, whereas
open-cell stents have larger gaps uncovered (Table I).5
Because of the possibility of restenosis and unknown
long-term durability of the procedure, strict follow-up and
surveillance are imperative after CAS.6,7 Duplex ultrasound
(DUS) imaging is the diagnostic modality of choice in the
follow-up of patients who undergo carotid revasculariza-
tion for carotid artery disease.6 Stented carotid arteries
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602have, however, shown artificially elevated blood flow veloc-
ities on postinterventional DUS scans.8 Several published
reports thus suggest ultrasound criteria for surveillance
need to be modified to define clinically significant in-stent
restenosis (ISR) after CAS.7,9,10 The effects of stent design
and other vessel characteristics on carotid velocities after
CAS remain to be established and quantified.
We analyzed our experience with DUS images ob-
tained immediately after CAS to assess stent design differ-
ences in carotid velocities that could alter baseline velocity
criteria for surveillance according to stent design.
METHODS
During a 3-year period, 141 CAS procedures were
done with cerebral embolic protection. Indications in-
cluded moderate (50%) symptomatic carotid stenosis
or severe (80%) asymptomatic carotid stenosis deter-
mined with DUS imaging. All CAS procedures were
performed under local anesthesia and intravenous seda-
tion through retrograde access from the common femo-
ral artery. All patients received dual antiplatelet therapy
with aspirin and a thienopyridine before the procedure
and perioperatively.
Completion carotid angiograms and postoperative
DUS images were obtained in all patients after CAS, and
the data derived from these tests were used for the analysis
in this study. Baseline and postoperative angiograms after
CAS procedures were performed with an OEC/GEModel
9800 mobile C-arm (OEC, Salt Lake City, Utah) or fixed
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Pa; or Allura Xper FD10, Philips, Bothell, Wash). Angio-
graphic projections that demonstrated the most severe
degree of stenosis were selected and used to assess the
degree of residual carotid in-stent stenosis according to the
North American Symptomatic Carotid Endarterectomy
(NASCET) criteria.11 Carotid tortuosity was graded ac-
cording to the vascular angulation from the proximal center
line flow as absent (0°), mild (30°), moderate (30° to
60°), or severe (60°).12,13
Procedural details and CAS protocols at our institution
followed techniques described in detail before.14 Briefly,
several types andmodels of cerebral protection devices were
used to prevent distal embolization: Abbott Accunet filter
(Acculink System, Abbott Vascular, Santa Clara, Calif),
FilterWire EZ system (Boston Scientific, Natick, Mass),
and Angioguard Filter (Cordis,Warren, NJ). The following
stents were available: Acculink carotid stent (Acculink Sys-
tem) and the Xact carotid stent (Abbott Vascular), Carotid
Wallstent and NEXSTENT carotid stent (Boston Scientific
Corp), and Precise and Protégé carotid stents (Cordis).
Carotid stent design choice was left to the discretion of the
operating surgeon, and all stent designs were equally avail-
able.
The DUS scans were performed using Phillips ATL
HDL 5000 SonoCT or IU 22 DU imaging systems (Both-
ell, WA) in two laboratories accredited by the Intersocietal
Commission for the Accreditation of Vascular Laborato-
ries. All studies were performed with the patients lying
supine on the examining table with their necks extended
45° toward the head of the table and rotated 45° away from
the examiner. Velocity measurements were made at 60°
insonation angles and were estimated using the software
included with the individual duplex scanner. The degree of
carotid stenosis was measured using velocities as well as the
location of the carotid bifurcation, the distal extent of
plaque, the diameter, and presence of redundancy or kink-
ing of the internal carotid artery. Carotid bifurcations were
imaged in transverse and longitudinal views.
Linear transducers in the 5- to 10-MHz range were
used to measure blood flow velocities at the proximal,
middle, and distal common carotid arteries (CCAs) and the
proximal external carotid artery (ECA). Velocities in the
proximal CCA and internal carotid artery (ICA) at proxi-
Table I. Stent types, design and free cell area used for
carotid stentinga
Stent type Stent design Free cell area (mm2)
Wallstent Closed cell 1.08
Xact Closed cell 2.74
Nexstent Closed cell 4.7
Precise Open cell 5.89
Protégé Open cell 10.71
Acculink Open cell 11.48
aAs reported by Bosiers et al.5mal, middle, and distal portions of the stent were carefullyassessed and recorded. Lower-frequency probes were used
as needed to evaluate the distal ICA or deep lying vessels.
ICA velocity was measured, if present, at the site of maxi-
mum residual in-stent stenosis.
For the purposes of our study, the DUS results were
interpreted as abnormal when carotid velocities met the
modified University of Washington previously validated
criteria modified for nonstented carotid arteries that use
digital subtraction angiography as the reference standard,
which consider ICA stenosis as moderate to severe when
the peak systolic velocity (PSV) is 125 cm/s and the
ICA/CCA PSV ratio is 2.0.10,15
Descriptive statistics for categoric variables are pre-
sented as relative frequencies and compared using 2 con-
tingency table analysis. Continuous variables were ex-
pressed as medians and interquartile ranges (IQR) and
means  standard deviation (SD). Data were then com-
pared with regard to stent-cell design using nonparametric
statistical tests due to the skewed distribution of the vari-
ables. Blood flow velocities were compared according to
stent design and type as independent samples using the
Mann-Whitney U test. Mantel-Haenszel common odds
ratio (OR) estimates are reported with 95% confidence
intervals (CI). The SAS 9.1 (SAS Institute, Cary, NC) and
MedCalc 9.5.1.0 (MedCalc Software, Mariakerke, Bel-
gium) software programs were used for data analyses.
RESULTS
Carotid DUS and angiographic imaging data for 141
CAS procedures performed in 121 men and 18 women
were analyzed; of these, 64 patients (45%) were treated for
symptomatic carotid artery stenosis and 77 patients (55%)
were asymptomatic. Indications for CAS included high
surgical risk due to severe comorbidities in 45%, hostile
neck in 22% (previous carotid endarterectomy, radical neck
dissection, radiation, permanent tracheostomy), high or
low primary or concomitant lesion in 19% (lesion above C2
or below the clavicle), and contralateral ICA occlusion in
14%. Successful revascularization (30% residual stenosis)
was achieved in all cases. Closed-cell stents were used in 41
CAS (29%) procedures and open-cell stents in 100 (71%).
No significant differences were noted in symptomatic sta-
tus, indications for CAS, carotid tortuosity, and residual
stenosis according to stent design. Acculink was the most
commonly used open-cell stent and was used in 77 patients
(57%; Table II). Wallstent was the most commonly used
closed-cell stent and was used in 39 patients (28%). The
proportion of stents used related to stent design is outlined
in Table II. Postintervention DUS images were obtained in
all patients within a median of 5 days (IQR, 1-25 days) after
CAS. The 30-day stroke-death rate in this series was 1.6%
and was unrelated to stent type.
The PSVwas significantly higher after CASwith closed-
cell stents (median, 122 cm/s; IQR, 89-143; mean  SD,
132  57) compared with open-cell stents (95.9 cm/s;
IQR, 77-123; mean SD, 103 37; P .007). EDV was
significantly higher for closed-cell stents (median, 36 cm/s,
IQR, 28-56; means  SD, 41  17) than for open-cell
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.006). The ICA/CCA PSV ratios were also significantly
higher for closed-cell stents than for open-cell stents
(means  SD, 2.1  3.1 vs 1.3  0.5, respectively). The
median ICA/CCA PSV ratios were 1.6 (IQR, 1.2-2.1) for
closed-cell stents and 1.2 (IQR, 0.9-1.5) for open-cell
stents (P  .017). Analysis confined to the Wallstent vs
Acculink, the most commonly used closed- and open-cell
stent types, respectively, also yielded significantly higher
median PSV (122 cm/s [IQR, 89-146] vs 95 cm/s [IQR,
78-119]), EDV (36 cm/s [IQR, 27-54] vs 30 cm/s [IQR,
24-38]), and ICA/CCA PSV ratio (1.6 [IQR, 1.1-2.20] vs
1.1 [IQR, 0.8-1.5]; P  .05).
According to modified University of Washington du-
plex velocity criteria, 45% of closed-cell stents had carotid
velocities that exceeded the threshold for moderate to
severe (50%) stenosis for a nonstented artery compared
with 26% of open-cell stents (P  .04; Table III). More-
over, closed-cell stents demonstrated a 2.26-fold increased
risk (OR, 2.26; 95% CI, 1.02-4.9) of having an abnormal
duplex result after CAS compared with open-cell stents.
With respect to the two extremes of stent design related to
free cell area, the Wallstent (smallest open free cell area)
demonstrated 2.63-fold increased odds of yielding an ab-
normal duplex result after CAS compared with the Accu-
Table II. Stent design and types used for carotid artery
stenting
Stent design and type No. (%)
Closed-cell stents
Wallstent 39 (28)
Xact 1 (0.8)
Nexstent 1 (0.8)
Open-cell stents
Acculink 77 (55)
Precise 22 (15)
Protégé 1 (0.8)
Table III. Duplex ultrasound results immediately after
carotid artery stenting to detect 50% stenosis using
validated criteria for nonstented carotid arteriesa,b
Duplex ultrasound results
Stent design, No. (%)
Total, No.Closed cell Open cell
Positive for 50% stenosis 17 (42) 24 (24) 41
Negative for 50% stenosis 24 (58) 76 (76) 100
Total 41 (100) 100 (100) 141
aUltrasound criteria for nonstented carotid arteries defined 50% carotid
stenosis according to modified University of Washington criteria: peak
systolic velocity (PSV) 125 cm/s and internal carotid artery-to-common
carotid artery PSV ratio 2.0.
bCompletion angiogram revealed successful revascularization in each case
and none had 30% residual stenosis.link stent (largest open free cell area).DISCUSSION
The results of our study indicate that significant stent
design differences in duplex velocities occur after CAS. In
fact, carotid blood flow velocities are significantly higher
after CAS with closed-cell stents compared with open-cell
stents. Our data also reveal that carotid blood flow veloci-
ties after CAS using closed-cell stents can more frequently
be considered abnormal according to established criteria
for nonstented carotid arteries compared with open-cell
stents. It remains unknown to what extent such stent
design differences in carotid velocities may influence DUS
criteria for restenosis and the incidence of ISR during
follow-up.
CAS has emerged as an alternative in the treatment of
carotid artery stenosis in selected populations.1,16 Despite
some early promising results, the long-term durability of
this treatment modality still remains in question.17 Al-
though DUS imaging is the most frequent imaging tech-
nique used in the follow-up and surveillance of patients
undergoing CAS, the application of current duplex criteria
for nonstented carotid arteries is unreliable.6,9,10,18-20 De-
spite the reported relatively low incidence of ISR after CAS,
select patients have a higher risk of recurrent disease, par-
ticularly those with a history of previous endarterectomy or
neck radiation.21 Therefore, it remains extremely impor-
tant to identify patients at risk for clinically significant ISR
as well as the duplex criteria to detect it. Current studies
have focused on identifying velocity criteria for stented
carotid arteries that better predict ISR. To our knowledge,
however, the effects of stent design on duplex flow veloci-
ties and ISR have not been explored.
Flexibility and scaffolding are key characteristics de-
rived from stent design.4 Closed-cell stents are less flexible
and may develop kinks and incomplete expansion. Con-
versely, stents with an open-cell configuration conform best
to angulated vessels or tortuous anatomy. In fact, the
differences in the functional properties of stent subgroups
are specifically related to the amount of free cell area
between scaffolding components.4 Scaffolding refers to the
amount of support given to the vessel wall by a stent. This
may hypothetically be important in the case of vulnerable
plaques, where insufficient scaffolding may cause distal
embolization and stroke if plaque material is squeezed
through the struts of the stent. Closed-cell stents could
potentially offer maximal scaffolding to the vessel wall. In
approximately 75% of all CAS procedures, either open- or
closed-cell stents may be used indiscriminately.22 For the
remaining fraction, careful preoperative screening is recom-
mended.
In addition to eventual access issues, the choice of the
optimal carotid stent depends mainly on arterial anatomic
characteristics and, to a lesser extent, lesion morphology.
Stents with a flexible and conformable open-cell configura-
tion are preferred in vessels that are angulated or have
tortuous anatomy. Lesions with suspected high embolic
potential could be primarily treated with stents with a
closed-cell configuration. Unfortunately, optimal clinical
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potential of certain lesions are still not available. The
potential hemodynamic effects of stent design on carotid
velocities and the subsequent risk of ISR remain un-
known and could also potentially influence the choice of
stent for CAS.
The importance of stent design has centered on the
periprocedural outcomes of CAS. Although direct compar-
isons of open- vs closed-cell stents have not been per-
formed, two observational studies from the same institu-
tion suggest that stents with a closed-cell design result in a
significant decrease in periprocedural neurologic events
after CAS.5,23 However, no significant differences in major
adverse events, including stroke-death rates, have been
reported in recent observational studies, registries, and
postmarketing studies of carotid stents efficacy among dif-
ferent stent designs.24-26 Prospective randomized clinical
trials comparing different free cell areas and stent designs
are necessary to further investigate their influence on CAS
outcomes and durability. Moreover, clear demonstration of
the efficacy and durability of closed-cell stents in preventing
cerebral embolization and adverse neurologic events would
be very important before adopting their widespread use
because this would come at the cost of more kinks, incom-
plete deployment, higher blood flow velocities, and turbu-
lence, all of which may occur more frequently with these
more rigid stents.
CAS clearly changes the vascular wall mechanical char-
acteristics of the carotid artery because stentingmakes it less
compliant and more rigid.6,8,27,28 In fact, a two-thirds
reduction in compliance of the carotid artery after CAS has
been demonstrated.6 This alteration in compliance may
contribute to the elevated velocities seen after CAS. Stent
design further plays a pivotal role in changing the compli-
ance of the carotid artery after CAS.22 Open-cell and
closed-cell stent designs differ in how they alter the carotid
wall mechanics, and such differences are mainly derived
from the stent architecture, as was mentioned. As a result,
closed-cell stents may yield vessels that are even less com-
pliant and more rigid than open-cell stents because of less
free cell area.
The differences in carotid blood flow velocities related
to stent design are intuitive, because principles of fluid
mechanics demonstrate that ventricular contraction would
be converted to an elevation in velocity in a less distensible
conduit rather than in increased arterial volume. Although
our data reveal that the absolute median PSVs are not
exceptionally elevated, the comparative elevation of veloc-
ities seen with closed-cell stents vs open-cell stents is signif-
icant. Admittedly, a limitation of our study is that the
elevation in velocities in our study was only demonstrated
in duplex scans obtained immediately after CAS, and it is
unknown if these elevations or the differential effect of
velocities related to stent design will persist in longer
follow-up. Clearly, this will warrant longer follow-up to
delineate.
Our data also suggest that the type of stent used (open
vs closed cell) and its effect on vessel compliance may havea critical role in developing duplex criteria for ISR.Defining
accurate duplex criteria for ISR according to stent design
will also help avoid the unnecessary risks of angiography-
related morbidity in these patients.
Although the present study includes a considerable
number of carotid interventions, important limitations
should be acknowledged. First, our study is an observa-
tional study and therefore nonrandomized. Second, stent
type choice was at the discretion of the interventionalist, a
source of possible selection bias. Third, stent type distribu-
tion was highly unbalanced, with only one predominant
stent type in each stent design group.
CONCLUSIONS
DUS imaging obtained immediately after CAS reveals
disproportionally elevated carotid velocities that are to
some extent related to stent design. The importance of
these differences in carotid velocities and their potential
relationship to recurrent stenosis remains to be established.
Further investigation and additional evaluation are war-
ranted to better define duplex criteria for restenosis and
long-term durability of CAS according to stent design.
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Dr Allen Hamdan (Boston, Mass). I think you bring up a
really crucial set of data here that we need to all look at, especially
as this becomes a more common situation. I am just going to go
right to some of the questions for the interest of time.
Have you looked at follow-up duplex—3, 6 months, a year
down the line—in these patients, and do these PSVs [peak systolic
velocities] persist over time, or is this just something you see early?
You didn’t mention anything on, or at least I didn’t see in the
paper, on recurrent stenosis. So was there a disproportionate
number of patients who had recurrent stenosis that maybe got
closed cells or open cells and that could have affected your data?
As a corollary, are there any other anatomic criteria that you
found, either on CTAs [computed tomography angiographies] or
angiograms that could have predicted, potentially, these changes?
And finally, have you looked at any of the published clinical
trials and looked at trials that had a higher proportion of closed-cell
stents, and in those trials is there a higher in-stent restenosis quoted
that maybe is a false elevation?
DrDamon S. Pierce. In answer, in brief, I think a few of your
questions dovetail into one, and that is that the data we have
presented were derived from immediate postintervention duplex
scans and we do not have a substantial follow-up data at this point.
That is what we plan to do, to see if these elevations and the
discrepancies persist through follow-up duplex examinations.
I don’t have any specific published reports that I can cite that
demonstrate disproportionality between closed- and open-cell
stents as you mention in regard to in-stent restenosis.
And no, we did not find any anatomic criteria for recurrent
stenosis.
Dr Massoud Alipour (Newport Beach, Calif). I’m a cardiol-
ogist and vascular technologist. I do hands-on studies. This is a fact
well known in the last, at least 4, 5 years, that intrastent velocity
increases because of very low compliance of the stent; therefore,
your systolic velocity is expected to rise and your diastolic velocity
is expected to decrease, not increase, because there is no reboundWhat you really considered false-positive, all of them are
true-negative. This shouldn’t be considered false-positive, because
even the criteria that you are using are very loose criteria. The
ICA/CCA [internal carotid artery/common carotid artery] veloc-
ity ratio of 1.7 is not significant at all. It should be considered
true-negative. And what you have mentioned about velocity of 125
normal and velocity ratio of 2, this should be consideredhemodynam-
ically not significant at all. So what you are mentioning as false-
positive, I believe, again, is true-negative and is quite expected.
Dr Pierce. That was not the aim of our study. The aim of our
study was to compare stent design differences in carotid velocities,
not in regard to the frequency of abnormal duplexes. We under-
stand that changes in elastic modulus generated by different stent
designs alter the compliance of the carotid artery after stenting.
What is significant in our data is the difference in carotid velocities
and the increased odds ratio of a closed-cell stents to yield abnor-
mal duplex velocities after carotid stenting.
Dr Jeffrey Hsu (Fontana, Calif). I just have a quick question
for you. First, a comment: We have also noticed an elevation of
velocities in our stents and we have been following our patients
with duplex. We have now changed our practice to get a postop-
erative duplex, basically prior to discharge, based on the assump-
tion that we are going to need some sort of baseline to compare to,
rather than to bring them back 6 to 8 weeks later, or 3 months or
other interval. So the question is, is a postprocedure ultrasound
before discharge something you recommend?
Dr Pierce. Well, it is tough to say based on these data, and I
think we will have more of an answer when we follow this subset of
patients to see if these elevations in velocities persist. But I think it
may be a good piece of data to have a baseline duplex before a
patient leaves the hospital.
Dr Martin Back (Tampa, Fla). Balloon size is going to
influence the residual diameter after angioplasty of stented stenoses
and therefore the postprocedural velocities. You need to make sure
that the balloon sizes that were used in your cases were equivalent
in those two groups for residual velocities to not differ.
